Skip to main content

Gynecologic Care and Contraception in the Medically Complex Adolescent

  • Chapter
Adolescent Gynecology
  • 919 Accesses

Abstract

When caring for adolescents and young women with chronic illnesses, it is important to address routine gynecologic care and your patient’s contraceptive needs to ensure her optimal health and avoid putting an unplanned pregnancy at risk for serious health effects to both the mother and/or the fetus. This chapter will review what special considerations need to be employed in routine gynecologic care for medically complex paients including Pap smear screening, STI screening, and HPV vaccination. In addition, this chapter will discuss special considerations to address your patient’s contraceptive needs. This will include how the chronic illness and the medications used to treat it interact with contraception and why it is important to consider the risk of pregnancy to your patient’s health and that of the fetus, in addition to issues of teratogenicity, thrombosis, contraceptive efficacy, continuation rates, and interactions with contraception and chronic illness medications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. ACOG Practice Bulletin Number 157: cervical cancer screening and prevention. Obstet Gynecol. 2016;127(1):e1–20.

    Google Scholar 

  2. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 14 May 2016.

  3. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2009. Atlanta: U.S. Department of Health and Human Services; 2010.

    Google Scholar 

  4. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med. 1998;338(7):423.

    Article  CAS  Google Scholar 

  5. Klumb EM, Araújo ML Jr, Jesus GR, et al. Is higher prevalence of cervical intraepithelial neoplasia in women with lupus due to immunosuppression? J Clin Rheumatol. 2010;16:153.

    Article  Google Scholar 

  6. Origoni M, Stefani C, Dell’Antonio G, et al. Cervical Human Papillomavirus in transplanted Italian women: a long-term prospective follow-up study. J Clin Virol. 2011;51(4):250–4.

    Article  Google Scholar 

  7. Ellerbrock TV, Chiasson MA, Bush TJ, et al. Incidence of cervical squamous intraepithelial lesions in HIV-infected women. JAMA. 2000;283(8):1031.

    Article  CAS  Google Scholar 

  8. Kane S, Khatibi B, Reddy D. Higher incidence of abnormal pap smears in women with inflammatory bowel disease. Am J Gastroenterol. 2007;103(3):631–6.

    Article  Google Scholar 

  9. Phipps W, Stanley H, Kohn R, Stansell J, Klausner JD. Syphilis, chlamydia, and gonorrhea screening in HIV-infected patients in primary care, San Francisco, California, 2003. AIDS Patient Care STDS. 2005;19(8):495.

    Article  CAS  Google Scholar 

  10. CDC, Health Resources and Services Administration, National Institutes of Health, American Academy of HIV Medicine, Association of Nurses in AIDS Care, International Association of Providers of AIDS Care, the National Minority AIDS Council, and Urban Coalition for HIV/AIDS Prevention Services. Recommendations for HIV prevention with adults and adolescents with HIV in the United States, 2014. http://stacks.cdc.gov/view/cdc/26062.

  11. Kumar D, Unger ER, Panicker G, Medvedev P, Wilson L, Humar A. Immunogenicity of quadrivalent human papillomavirus vaccine in organ transplant recipients. Am J Transplant. 2013;13(9):2411–7. Epub 2013 Jul 9.

    Article  CAS  Google Scholar 

  12. Markowitz LE, Dunne EF, Saraiya M, Lawson HW, Chesson H, Unger ER, Centers for Disease Control and Prevention (CDC), Advisory Committee on Immunization Practices (ACIP). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1.

    PubMed  Google Scholar 

  13. Robinson CL, Advisory Committee on Immunization Practices (ACIP), ACIP Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years – United States, 2016. MMWR Morb Mortal Wkly Rep. 2016;65(4):86–7.

    Article  Google Scholar 

  14. Guazzelli CAF, Torloni MR, Sanches TF, et al. Contraceptive counseling and use among 197 female kidney transplant recipients. Transplantation. 2008;86:669.

    Article  Google Scholar 

  15. Medical eligibility criteria for contraceptive use. 4th ed. World Health Organization. 2015. http://www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/. Accessed 25 April 2016.

  16. U.S. Medical Eligibility Criteria for contraceptive use, 2010: adapted from the World Health Organization medical eligibility criteria for contraceptive use. 4th ed. http://www.cdc.gov/reproductivehealth/unintendedpregnancy/usmec.htm. Accessed 25 April 2016.

  17. Petri M, Kim MY, Kalunian KC, et al. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2550–8.

    Article  CAS  Google Scholar 

  18. Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, et al. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med. 2005;353:2539–49.

    Article  CAS  Google Scholar 

  19. Choojitarom K, Verasertniyom O, Totemchokchyakarn K, et al. Lupus nephritis and Raynaud’s phenomenon are significant risk factors for vascular thrombosis in SLE patients with positive antiphospholipid antibodies. Clin Rheumatol. 2008;27:345–51.

    Article  Google Scholar 

  20. Wahl DG, Guillemin F, de Maistre E, et al. Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus–a meta-analysis. Lupus. 1997;6:467–73.

    Article  CAS  Google Scholar 

  21. Finer LB, Zolna MR. Declines in unintended pregnancy in the United States, 2008–2011. N Engl J Med. 2016;374(9):843–85.

    Article  CAS  Google Scholar 

  22. Steinkellner A, Chen W, Denison SE. Adherence to oral contraception in women on Category X medications. Am J Med. 2010;123(10):929.

    Article  Google Scholar 

  23. Hatcher RA. Contraceptive technology. 20th ed. Bridging the Gap Communications; 2011.

    Google Scholar 

  24. Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397.

    Article  Google Scholar 

  25. Rosenstock JR, Peipert JF, Madden T, Zhao Q, Secura GM. Continuation of reversible contraception in teenagers and young women. Obstet Gynecol. 2012;120(6):1298–305.

    Article  Google Scholar 

Suggested Educational Reading, References, and Policies

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Amanda M. Jacobs M.D. .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG

About this chapter

Cite this chapter

Jacobs, A.M. (2018). Gynecologic Care and Contraception in the Medically Complex Adolescent. In: Talib, H.J. (eds) Adolescent Gynecology. Springer, Cham. https://doi.org/10.1007/978-3-319-66978-6_22

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-66978-6_22

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-66977-9

  • Online ISBN: 978-3-319-66978-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics